Literature DB >> 36094686

Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients.

Gwyneth Kong1, Nicholas W S Chew2, Cheng Han Ng1, Yip Han Chin1, Rebecca Zeng1, Roger Foo1,3, Koo Hui Chan1,3, Adrian Fatt-Hoe Low1,3, Chi-Hang Lee1,3, Mark Yan-Yee Chan1,3, Tiong-Cheng Yeo1,3, Huay-Cheem Tan1,3, Poay-Huan Loh1,3.   

Abstract

A sizeable number of patients without standard modifiable cardiovascular risk factors (SMuRFs), such as hypertension, diabetes, hypercholesterolemia and smoking, suffer from acute coronary syndrome (ACS). These SMuRF-less patients have high short-term morbidity and mortality. We compared both short- and long-term outcomes of SMuRF-less and SMuRF ACS patients in a multi-ethnic Asian cohort.This was a retrospective study of patients with first ACS from 2011 to 2017. The primary outcome was long-term all-cause mortality. Secondary outcomes were 30-day all-cause mortality, cardiac-mortality, unplanned cardiac readmission, cardiogenic shock, heart failure, and stroke. Subgroup analysis was carried out by sex and ACS type.Of 5400 patients, 8.6% were SMuRF-less. The median follow-up time was 6.3 years (interquartile range [IQR] 4.2-8.2 years). SMuRF-less patients were younger and tended to present with ST-segment elevation myocardial infarction (STEMI). They were more likely to require inotropic support, intubation, and have cardiac arrest. At 30 days, SMuRF-less patients had higher rates of all-cause mortality, cardiac-related mortality and cardiogenic shock, but lower rates of heart failure. At 6 years, all-cause mortality was similar in both groups (18.0% versus 17.1% respectively, p = 0.631). Kaplan-Meier curves showed increased early mortality in the SMuRF-less group, but the divergence in survival curves was no longer present in the long-term. The absence of SMuRF was an independent predictor of mortality, regardless of sex or ACS type.In a multi-ethnic cohort of patients with ACS, SMuRF-less patients were observed to have higher mortality than SMuRF patients during the early stages which was attenuated over time.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute Coronary Syndrome; Prognostic outcomes; Standard modifiable cardiovascular risk factors

Year:  2022        PMID: 36094686     DOI: 10.1007/s11239-022-02704-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   5.221


  4 in total

1.  Myocardial layer-specific effect of myoblast cell-sheet implantation evaluated by tissue strain imaging.

Authors:  Yasuhiro Shudo; Shigeru Miyagawa; Satoshi Nakatani; Satsuki Fukushima; Taichi Sakaguchi; Atsuhiro Saito; Toshihiko Asanuma; Naomasa Kawaguchi; Nariaki Matsuura; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Circ J       Date:  2012-12-29       Impact factor: 2.993

2.  Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study.

Authors:  Ping Li; Hongyan Zhang; Caidong Luo; Zheng Ji; Zeqi Zheng; Zhenyong Li; Fan Wu; Jinlong Li; Lang Hong
Journal:  Front Cardiovasc Med       Date:  2022-04-29

3.  Comparison of cusp-overlap projection and standard three-cusp coplanar view during self-expanding transcatheter aortic valve replacement: A systematic review and meta-analysis.

Authors:  Yujing Chen; Gangjie Zhu; Xin Liu; Weilin Wu; Hui Chai; Minjie Tao; Dongmei Kong; Yingzi Li; Li Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.